Wordt geladen...
In Vivo and In Vitro Ivacaftor Response in Cystic Fibrosis Patients With Residual CFTR Function: N-of-1 Studies
Rationale: Ivacaftor, a cystic fibrosis transmembrane conductance regulator (CFTR) potentiator, decreases sweat chloride concentration, and improves pulmonary function in 6% of cystic fibrosis (CF) patients with specific CFTR mutations. Ivacaftor increases chloride transport in many other CFTR mutat...
Bewaard in:
| Gepubliceerd in: | Pediatr Pulmonol |
|---|---|
| Hoofdauteurs: | , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5461115/ https://ncbi.nlm.nih.gov/pubmed/28068001 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ppul.23659 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|